BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16690295)

  • 1. [Chronic autoimmune hemolytic anemia: toward new treatments?].
    Bader-Meunier B; Leverger G
    Arch Pediatr; 2006 Jun; 13(6):517-9. PubMed ID: 16690295
    [No Abstract]   [Full Text] [Related]  

  • 2. [New treatments for systemic diseases].
    Bader-Meunier B; Willems M
    Arch Pediatr; 2006 Jun; 13(6):596-8. PubMed ID: 16690273
    [No Abstract]   [Full Text] [Related]  

  • 3. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical stem cell transplantation.
    Ship A; May W; Lucas K
    Bone Marrow Transplant; 2002 Feb; 29(4):365-6. PubMed ID: 11896436
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-CD20 monoclonal antibody for the treatment of refractory autoimmune hemolytic anemia].
    Wang L; Xu W; Li JY; Xie XY; Sheng RL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):425-8. PubMed ID: 17493362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alemtuzumab for giant cell hepatitis with autoimmune hemolytic anemia.
    Rovelli A; Corti P; Beretta C; Bovo G; Conter V; Mieli-Vergani G
    J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):596-9. PubMed ID: 18030239
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolate mofetil for severe autoimmune haemolytic anemia.
    Zimmer-Molsberger B; Knauf W; Thiel E
    Lancet; 1997 Oct; 350(9083):1003-4. PubMed ID: 9329520
    [No Abstract]   [Full Text] [Related]  

  • 8. [Autoimmune hemolytic anemia].
    Karasawa M
    Nihon Rinsho; 2008 Mar; 66(3):520-3. PubMed ID: 18326320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood refractory autoimmune haemolytic anaemia: is there a role for anti-CD20 therapy (rituximab)?
    McMahon C; Babu L; Hodgson A; Hayat A; Connell NO; Smith OP
    Br J Haematol; 2002 May; 117(2):480-3. PubMed ID: 11972537
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful induction and maintenance of long-term remission in a child with chronic relapsing autoimmune hemolytic anemia using rituximab.
    Gottardo NG; Baker DL; Willis FR
    Pediatr Hematol Oncol; 2003; 20(7):557-61. PubMed ID: 12959862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoimmune haemolytic anemia: diagnosis strategy and new treatments].
    Rigal D; Meyer F
    Transfus Clin Biol; 2011 Apr; 18(2):277-85. PubMed ID: 21474357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of stiff person syndrome with rituximab.
    Baker MR; Das M; Isaacs J; Fawcett PR; Bates D
    J Neurol Neurosurg Psychiatry; 2005 Jul; 76(7):999-1001. PubMed ID: 15965211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (rituximab).
    Ahrens N; Kingreen D; Seltsam A; Salama A
    Br J Haematol; 2001 Jul; 114(1):244-5. PubMed ID: 11472378
    [No Abstract]   [Full Text] [Related]  

  • 14. Rituximab: a very efficient therapy in cold agglutinins and refractory autoimmune haemolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma.
    Bauduer F
    Br J Haematol; 2001 Mar; 112(4):1085-6. PubMed ID: 11324638
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti B cell targeted immunotherapy for treatment of refractory autoimmune haemolytic anaemia in a young infant.
    Ng PC; Lee KK; Lo AF; Li CK; Fok TF
    Arch Dis Child; 2003 Apr; 88(4):337-9. PubMed ID: 12651764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD20 monoclonal antibody for the treatment of refractory autoimmune haemolytic anaemia associated with idiopathic membranous nephropathy.
    Rossi P; Demoux AL; Granel B; Bagnères D; Bonin-Guillaume S; Frances Y
    Rheumatology (Oxford); 2005 Mar; 44(3):403-5. PubMed ID: 15637040
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.
    Rao VK; Dugan F; Dale JK; Davis J; Tretler J; Hurley JK; Fleisher T; Puck J; Straus SE
    Br J Haematol; 2005 May; 129(4):534-8. PubMed ID: 15877736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic stem cell transplantation for Evans syndrome.
    Oyama Y; Papadopoulos EB; Miranda M; Traynor AE; Burt RK
    Bone Marrow Transplant; 2001 Nov; 28(9):903-5. PubMed ID: 11781654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease.
    Berentsen S; Tjønnfjord GE; Brudevold R; Gjertsen BT; Langholm R; Løkkevik E; Sørbø JH; Ulvestad E
    Br J Haematol; 2001 Oct; 115(1):79-83. PubMed ID: 11722415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment with rituximab and mycophenolate mofetil of refractory autoimmune hemolytic anemia post-hematopoietic stem cell transplant for dyskeratosis congenita due to TINF2 mutation.
    O'Connell N; Goodyer M; Gleeson M; Storey L; Williams M; Cotter M; O'Marcaigh A; Smith O
    Pediatr Transplant; 2014 Feb; 18(1):E22-4. PubMed ID: 24168326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.